Member Log In

Reliant Glycosciences LLC receives $1.2M towards research

20 Jun 2022 5:53 PM | Anonymous member (Administrator)

A University of Alabama at Birmingham biotech startup received $1.2 million to continue research toward treating a chronic kidney disease.

Reliant Glycosciences LLC received a National Institutes of Health Small Business Innovation Research Phase II award to continue the development of its IgA nephropathy-related biomarker assays. The award runs through spring 2024.

Read full article HERE.

Connecting the Bioscience Ecosystem in Alabama

BIO Alabama
100 Drake Dr., Unit 688
Normal, AL 35762

administrator@bioalabama.com

© BIO Alabama

Powered by Wild Apricot Membership Software